Latebreakers: Combo diabetes drug gets FDA nod

April 16, 2007

Article

The FDA has approved the combination of sitagliptin (Januvia, Merck) and metformin for the treatment of Type 2 diabetes.

Related Content

Register Today: April 2024 Total Pharmacy Solutions Summit

April 1st 2024

Article

The can’t-miss event on April 13 features speakers and CE sessions focused on elevating patient-centric care.

Looking to the Future of Independent Pharmacy

July 13th 2022

Podcast

Don Arthur, RPh, discusses what lays ahead in independent pharmacy, from clinical care to success stories.

Pharmacists Play Unique Role in Advancing Health Equity for Patients With Chronic Disease

December 7th 2023

Article

A new study, outlined in a poster at ASHP Midyear 2023, identified 3 key themes associated with the ways in which pharmacists are positioned to advance health equity for patients with chronic diseases.

Podcast: Pharmacy Financing With First Financial Bank

January 28th 2022

Podcast

Learn more about the ins and outs of pharmacy ownership from the experts at First Financial Bank.

Assessing Financial Impacts of Pharmacist-Led Interventions in Pediatric Ambulatory Care

December 5th 2023

Article

According to a poster abstract presented at the ASHP Midyear Clinical Meeting & Exhibition, specialty pharmacy services were used for a variety of conditions that have been reported in adult populations.